NCT07522177 Animated Storytelling to Promote Colorectal Cancer Screening
| NCT ID | NCT07522177 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Colorectal Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2026-10-16 |
| Primary Completion | 2026-11 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,000 participants in total. It began in 2026-10-16 with a primary completion date of 2026-11.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This online randomized controlled trial will evaluate whether a short animated storytelling video increases behavioral expectation to obtain colorectal cancer screening among screening-eligible U.S. adults who report not yet having completed screening. Participants will be recruited via Prolific and randomized in Stanford Qualtrics to view either a brief animated video or a time-neutral informational text. Outcomes will be assessed immediately after exposure.
Eligibility Criteria
Inclusion Criteria: * Resides in the United States * Able to read and understand English * Self-reports not having completed colorectal cancer screening * Provides electronic informed consent Exclusion Criteria: * Prior diagnosis of colorectal cancer * Self-reported completion of colorectal cancer screening
Contact & Investigator
Maya Adam, MD, PhD
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT07522177 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Colorectal Cancer Screening. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07522177 currently recruiting?
Yes, NCT07522177 is actively recruiting participants. Visit ClinicalTrials.gov or contact Stanford University to inquire about joining.
Where is the NCT07522177 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT07522177 clinical trial?
NCT07522177 is sponsored by Stanford University. The principal investigator is Maya Adam, MD, PhD at Stanford University. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.